Bioventus Inc.
Bioventus Inc.（BVS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bvs · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$13.00
Consensus
$13.00
+44.5% upside
Low
$13.00
Median: $13 · Last Close: $8.99
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.55 | ↓ 5.00% |
1-day model range: $8.49–$8.6. Peak: $8.6 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $11 | +18.3% |
| 2028 | $12 | +30.3% |
| 2029 | $12 | +37.5% |
| 2030 | $13 | +41.7% |
| 2031 | — | +44.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BVS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-06 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-06 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-12-17 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2024-11-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-09-27 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-08-07 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-05-08 | Canaccord Genuity | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bioventus Inc. (BVS) stock. Of the recent 31 rating actions, 2 were upgrades and 4 were downgrades. 6 analysts currently cover BVS.
分析师推荐趋势
BVS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$605M
↓ 11.7% YoY
Revenue Next Year
$645M
↑ 6.6% YoY
EPS This Year
$0.78
EPS Next Year
$0.91
↑ 16.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast BVS EPS of $0.78 for the current fiscal year, based on estimates from 4 analysts. The BVS revenue forecast is $605M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BVS 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BVS 的共识目标价为 $13.00（+44.5% 上行空间），分析师共识为 Buy。
BVS 的短期预测（明日）为 $8.55（-5.00%）。 BVS 对 2027 年的股价预测均值为 $11。 BVS 对 2030 年的预测区间为 $12–$14。
Bioventus Inc. 在 NASDAQ 上市，代码 BVS。BVS 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
BVS 预测 · 8 个问题根据 6 位华尔街分析师，BVS 的 12 个月平均目标价为 $13.00，最高 $13.00、最低 $13.00。若有图表，中位目标价可在上方查看。相对当前价 $8.99，隐含约 +44.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.